OSR Health (OSRH) is up 76.8% today. Here is some analysis on what might have caused this price movement.
Analysis: A clear same-day catalyst is hard to pin down, so this looks at least partly speculative. The move may reflect renewed attention on OSR Health’s VXM01 oncology licensing deal, its related equity support features, and the kind of momentum-driven trading that often appears in small-cap biotech names facing a near-term Nasdaq compliance deadline.
Details:
Sources:
SEC, OSR Health, Nasdaq
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$OSRH Hedge Fund Activity
We have seen 7 institutional investors add shares of $OSRH stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 127,810 shares (+inf%) to their portfolio in Q2 2026, for an estimated $40,426
- JANE STREET GROUP, LLC added 127,195 shares (+inf%) to their portfolio in Q2 2026, for an estimated $40,231
- TWO SIGMA SECURITIES, LLC added 46,537 shares (+inf%) to their portfolio in Q2 2026, for an estimated $14,719
- TORONTO DOMINION BANK removed 40,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $12,652
- XTX TOPCO LTD removed 28,366 shares (-46.7%) from their portfolio in Q2 2026, for an estimated $8,972
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 18,282 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,782
- STONEX GROUP INC. removed 15,435 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $4,882
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.